BMedSc (Hons), MBBS (Hons) Monash, MD Monash, FRACP, F Thor Soc

Jo Douglass is a specialist physician with clinical and research interests in Asthma and Allergic disease. She is currently appointed as a specialist physician and Director of Research at the Royal Melbourne Hospital. She is also a Professor of Medicine at the University of Melbourne.

She sees adults and adolescents 12 years or older in the practice.

Jo Douglass is a specialist physician who trained in Respiratory Medicine and in Allergy and Clinical Immunology in Australia and the UK. She currently holds appointments as the James Stewart Professor of Medicine in the Department of Medicine, University of Melbourne and also is Director of Research at the Royal Melbourne Hospital. Between 2012 to 2019 she was the head of the Department of Immunology and Allergy at the Royal Melbourne Hospital. In 2013 she was awarded a Fellowship of the Thoracic Society of Australia and New Zealand, an award acknowledging exceptional contribution to Respiratory Health in Australia.

She graduated from Monash University and holds an MD by research with over 100 academic publications and current research projects in asthma and immune disorders, especially epidemic thunderstorm asthma and the genomics of primary immune deficiencies. Clinically she enjoys caring for people with allergies and has a special interest in severe asthma.

Jo also has active community roles. She is married, the mother of two teenagers and enjoys walking her dog, cooking and horse riding - when she can find the time!

Royal Melbourne Hospital
University of Melbourne

  Declaration of commercial interests

In the past 5 years, Jo has been principal investigator for trials of novel treatments in respiratory disease, allergy and immune deficiencies conducted at the Royal Melbourne Hospital. These studies have been sponsored by GSK, Astra-Zeneca, Novartis, Sanofi-Aventis, CSL and Grifols. She has received honoraria for presentations and for being a member of advisory boards from GSK, Astra-Zeneca, Novartis, Pieris, Stallergenes and Seqirus.

  Media Articles

  Media Interviews

  • 16th Nov 2017: 3AW, A bee sting can be far more dangerous than you think, expert warns
  • 21st Feb 2011: Herald Sun, Channel 9 news: food additives in supermarkets.
  • 2nd July 2011: National Asthma Council of Australia spokesperson medication adherence campaign. National news, radio and newspaper.
  • 10 Network Television News: 11th March 2011. Anaphylaxis e-training for Health Professionals
  • ABC Radio Melbourne: Noni Hazelhurst: “Food Allergy”. 7:30 Saturday 8th January 2011
  • National News: Channel 2,7,9 10 Melbourne Tuesday 23rd November : Thunderstorm Asthma
  • ABC Radio Melbourne: Noni Hazelhurst: “Hay Fever”. 2:30 Monday 1st November 2010
  • ABC Radio Melbourne: Hilary Harper “Food Allergy”. 07:00 Saturday 24th July 2010
  • Channel 7 News: Hay Fever 22 Oct 2009
  • Herald Sun Newspaper: Quoted Hay Fever on the rise. 21 Oct 2009

  Selected Publications

  1. Holgate ST, Douglass JA (eds) Fast Facts: Asthma (4th Ed) Health Press Ltd , Abingdon, Oxford OX14 3LN, UK. 2013
  2. Thompson BR, Douglass JA, Ellis MJ, Kelly VJ, O'Hehir RE, King GG, Verbanck S. Peripheral Lung Function in patients with stable and unstable asthma. Journal of Allergy and Clinical Immunology 2013; 131: 1322-1328.
  3. Chua JC, Douglass JA, Gillman A, O'Hehir RE, Meeusen EN (2012) Galectin-10, a Potential Biomarker of Eosinophilic Airway Inflammation. PLoS ONE 7(8): e42549. doi:10.1371/journal.pone.0042549
  4. Douglass, JA, Goeman, DP, McCarthy, EA, Sawyer, SM, Aroni, RA, Stewart, K, Abramson, Michael J. Over-the-counter β2-agonist purchase versus script: a cross-sectional study. Respir Med. 2012 Feb;106(2):223-9.
  5. Chen Y, Stirling R, Hore-Lacy F, Thompson B, Douglass JA. Longitudinal decline in lung function in patients with primary immunoglobulin deficiencies. J Allergy Clin Immunol 2011. 127: 1414-7
  6. Gillman A, Douglass JA. What do asthmatics have to fear from food and additive allergy? Clin Exp Allergy 2010; 40: 1295-1302.
  7. O'Hehir RE, Gardner LM, de Leon MP, Hales BJ, Biondo M, Douglass JA, Rolland JM, Sandrini A. House dust mite sublingual immunotherapy: the role for transforming growth factor-beta and functional regulatory T cells. Am J Respir Crit Care Med 2009; 180: 936-47.
  8. Douglass JA, Carroll K, Voskamp A, Bourke P, Wei A, O’Hehir RE. Omalizumab is effective in treating systemic mastocytosis in a non-atopic patient. Allergy 2010; 65: 926-7. DOI: 10. 1111/ J.1398-99 95.2009.02259
  9. Goeman DP, Sanci LA, Scharf SL, Bailey M, O’Hehir RE, Jenkins CR, Douglass JA. Improving general practice consultations for older people with asthma: a cluster-randomised controlled trial. Med J Aust 2009; 191: 113-117.
  10. Douglass JA, O’Hehir RE. Diagnosis, treatment and prevention of allergic disease: the basics. Med J Aust 2006; 185: 228-233. [Free access to full article at the MJA]
  11. Holzer K, Anderson S, Chan H, Douglass J. Mannitol as a challenge test to identify exercise-induced bronchoconstriction in elite athletes. Am J Respir Crit Care Med 2003; 167: 534-537.
  12. Holzer K, Anderson SD, Douglass J. Asthma in elite summer athletes: challenges for diagnosis. J Allergy Clin Immunol 2002; 110: 374-80.
  13. Douglass J, Aroni R, Goeman D, K Stewart, S Sawyer, F Thien, M Abramson. A qualitative study of action plans for asthma. BMJ 2002; 324: 1003-1005. [Free access to full article at the BMJ]

Level 1, Suite 123
Chelsea House
55 Flemington Road
North Melbourne VIC 3051

  Getting Here

CONTACT US

FAX:  03 9326 8444
  reception@allergyasthma.com.au

  03 9328 4573

  03 9326 8444
  Email Us

© 2018-2021 Melbourne Allergy Asthma & Immunology Consultants | Privacy Policy | Disclaimer | Website design: WebInjection